| Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines A Kužnik, M Benčina, U Švajger, M Jeras, B Rozman, R Jerala The Journal of Immunology 186 (8), 4794-4804, 2011 | 676 | 2011 |
| C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity U Švajger, M Anderluh, M Jeras, N Obermajer Cellular signalling 22 (10), 1397-1405, 2010 | 295 | 2010 |
| Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases U Švajger, M Jeras International reviews of immunology 31 (3), 202-222, 2012 | 186 | 2012 |
| IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments N Vardjan, M Gabrijel, M Potokar, U Švajger, M Kreft, M Jeras, Y de Pablo, ... Journal of neuroinflammation 9, 1-13, 2012 | 112 | 2012 |
| Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation U Švajger, N Obermajer, M Jeras Immunology 129 (4), 525-535, 2010 | 112 | 2010 |
| Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. M Krasna, D Domanović, A Tomsic, U Svajger, M Jeras Acta dermatovenerologica Alpina, Pannonica, et Adriatica 16 (3), 105-110, 2007 | 110 | 2007 |
| The tolerogenic role of IFN-γ P Rožman, U Švajger Cytokine & Growth Factor Reviews 41, 40-53, 2018 | 72 | 2018 |
| Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation U Švajger, P Rožman Journal of leukocyte biology 95 (1), 53-69, 2014 | 67 | 2014 |
| Chemical composition of the silver fir (Abies alba) bark extract Abigenol® and its antioxidant activity ET Benković, T Grohar, D Žigon, U Švajger, D Janeš, S Kreft, B Štrukelj Industrial crops and products 52, 23-28, 2014 | 63 | 2014 |
| Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X N Obermajer, U Švajger, M Bogyo, M Jeras, J Kos Journal of Leucocyte Biology 84 (5), 1306-1315, 2008 | 60 | 2008 |
| Design, synthesis, biochemical evaluation and antimycobacterial action of phosphonate inhibitors of antigen 85C, a crucial enzyme involved in biosynthesis of the mycobacterial … S Gobec, I Plantan, J Mravljak, U Švajger, RA Wilson, GS Besra, ... European journal of medicinal chemistry 42 (1), 54-63, 2007 | 60 | 2007 |
| Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists N Obermajer, S Sattin, C Colombo, M Bruno, U Švajger, M Anderluh, ... Molecular Diversity 15, 347-360, 2011 | 59 | 2011 |
| DC-SIGN antagonists, a potential new class of anti-infectives M Anderluh, G Jug, U Svajger, N Obermajer Current medicinal chemistry 19 (7), 992-1007, 2012 | 55 | 2012 |
| Cystatin F affects natural killer cell cytotoxicity M Perišić Nanut, J Sabotič, U Švajger, A Jewett, J Kos Frontiers in immunology 8, 1459, 2017 | 54 | 2017 |
| Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells Š Magister, N Obermajer, B Mirković, U Švajger, M Renko, A Softić, ... European journal of cell biology 91 (5), 391-401, 2012 | 53 | 2012 |
| In vitro impact of bisphenols BPA, BPF, BPAF and 17β-estradiol (E2) on human monocyte-derived dendritic cell generation, maturation and function U Švajger, MS Dolenc, M Jeras International immunopharmacology 34, 146-154, 2016 | 48 | 2016 |
| Induction of tolerogenic dendritic cells by endogenous biomolecules: an update U Švajger, P Rožman Frontiers in immunology 9, 417023, 2018 | 44 | 2018 |
| Novel toll-like receptor 4 (TLR4) antagonists identified by structure-and ligand-based virtual screening U Švajger, B Brus, S Turk, M Sova, V Hodnik, G Anderluh, S Gobec European journal of medicinal chemistry 70, 393-399, 2013 | 44 | 2013 |
| Monovalent mannose-based DC-SIGN antagonists: Targeting the hydrophobic groove of the receptor T Tomašić, D Hajšek, U Švajger, J Luzar, N Obermajer, I Petit-Haertlein, ... European Journal of Medicinal Chemistry 75, 308-326, 2014 | 41 | 2014 |
| Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4 U Švajger, A Vidmar, M Jeras International immunopharmacology 8 (7), 997-1005, 2008 | 41 | 2008 |
